M/S. RANBAXY LABORATORIES LIMITED,NEW DELHI vs. ADDL. CIT, NEW DELHI

In the result, the appeal of the assessee in IT(TP) A No

Bench: Justice P.P. Bhatt & Shri Waseem Ahmed1. आयकर अपील सं./It(Tp)A No. 1782/Del/2014 2. आयकर अपील सं./It(Tp)A No. 781/Del/2015 ("नधा"रण वष"/Assessment Years : 2009-10 & 2010-11) Ranbaxy Laboratories Ltd. The Dcit बनाम/ 12Th Floor, Devika Tower Circle-21(1), New Vs. 6, Nehru Place, New Delhi Delhi/ 110 019 Addl.Cit Range-15 New Delhi "थायी लेखा सं./जीआइआर सं./Pan/Gir No. : Aaacr0127N .. (अपीलाथ"/Appellant) (""यथ" / Respondent) अपीलाथ" ओर से/ Appellant By : Shri S.N.Soparkar, Shri Vartik Chokshi, Ms.Urvashi Shodhan & Shri P.Shah, Ars ""यथ" क" ओर से/Respondent By: Shri Mahesh Shah, Cit-Dr

disallowing the adjustment concerning loss on contribution to US regulatory condition, R&D expenses and some other expenses which were treated by the assessee as non-operating expenses but the TPO treated them as operating expenses. Thus the TPO determined the PLI of the assessee at - 5.35%. 5.21. In view of the above facts, the TPO issued

THE DY.CIT.,CIRCLE-2(1)(1),, AHMEDABAD vs. INDUCTOTHERM (INDIA) PRIVATE LTD., AHMEDABAD

In the result, the appeal of the revenue is dismissed

section 143(3) r.w.s. 144C & 92CA(3) of the Income Tax Act, 1961; in short “the Act”. 2. The Revenue has raised following grounds of appeal:- “1. The Ld CIT(A) had erred in law and on facts in deleting the upward adjustment of Rs 1,12,25,575/- made by the TPO on benchmarking of Royalty payments 2